Regional News

Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI321 (Anti-PD-1/TIGIT Bispecific Antibody) in Patients with Advanced Malignant Tumors

SAN FRANCISCO and SUZHOU, China, July 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-07-26 08:00 7800

ZumVet launches first virtual veterinary platform in Hong Kong

HONG KONG, July 26, 2021 /PRNewswire/ -- Singapore-based pet telehealth startup ZumVet today announced the launch of its platform inHong Kong, a remote care solution offering a full suite of home-based health and wellness services for pets. This is the first pet-centric app of its kind inHong ...

2021-07-26 06:00 4286